Sign up

Experience where it matters.

For more than 30 years, healthcare providers and people with rare bleeding disordersa have trusted NovoSeven® RT. It’s the first and only recombinant factor VIIa (rFVIIa) that is:

Checkmark icon

Indicated for people of all agesb   

Checkmark icon

Approved for use before, during, and after surgery and procedures

Checkmark icon

Safe when used with Hemlibra

Take a Closer Look

aFor people with hemophilia A or B with inhibitors.
bIn people with acquired hemophilia, NovoSeven® RT is only indicated for adults.

Krystal and her son Dallas, who lives with
Glanzmann’s thrombasthenia (GT) with resistance
to platelets and uses NovoSeven® RT.

Experience where it matters.

For more than 30 years, healthcare providers and people with rare bleeding disordersa have trusted NovoSeven® RT. It’s the first and only recombinant factor VIIa (rFVIIa) that is:

  • Indicated for people of all agesb
  • Approved for use before, during, and after surgery and procedures
  • Safe when used with Hemlibra

Take a Closer Look

aFor people with hemophilia A or B with inhibitors.
bIn people with acquired hemophilia, NovoSeven® RT is only indicated for adults.

Krystal and her son Dallas, who lives with Glanzmann’s thrombasthenia (GT) with resistance to platelets and uses NovoSeven® RT.

Is NovoSeven® RT right for you?

See how NovoSeven® RT can help you control bleeds related to:

Hemophilia A with inhibitors

Hemophilia B with inhibitors

Factor VII deficiency

Glanzmann's thrombasthenia when platelets don't work

Acquired hemophilia

Syringe and vials of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Safety profile with proven experience.

NovoSeven® RT is designed with your safety in mind. It’s safe for use with Hemlibra if you have hemophilia A with inhibitors. Studies also show it has a low rate of thrombotic adverse events (blood clots).c

View safety information

cThe most common and serious side effects are blood clots.

Miguel lives with hemophilia B with inhibitors and Taylor lives with FVIId

Your treatment, your way.

Your treatment should accommodate your lifestyle—take it from people who choose NovoSeven® RT. Hear from others with rare bleeding disorders to learn what makes this treatment the right choice for them.

Hear their stories

Hemophilia Community Liaisons for NovoSeven® RT

How can we help?

Novo Nordisk Hemophilia Community Liaisons (HCLs) are here to answer your questions about NovoSeven® RT and connect you with resources to help you manage your bleeding disorder.

Connect with an HCL

New to NovoSeven® RT?

Here’s how to get started:

New to NovoSeven® RT? Here’s how to get started:

I have just been prescribed NovoSeven® RT.

Let’s Get Started

I am considering NovoSeven® RT.

See the Details

Selected Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT

What is NovoSeven® RT?

NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness

What should I tell my healthcare provider before using NovoSeven® RT?

  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
    • congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
    • are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
    • history of heart or blood vessel diseases
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies

What are the possible side effects of NovoSeven® RT?

  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction

Please click here for Prescribing Information